Clinical Trial Update: Phase Ib Study of Chiauranib in Patients With Ovarian Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase Ib study updates on chiauranib in ovarian cancer; trial phases include Phase 1 and Phase 2 and the study is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ovarian Cancer

Drugs mentioned

• Chiauranib (Chiauranib)

Snippet

Sponsor: Chipscreen Biosciences, Ltd. | Conditions: Ovarian Cancer | Phase 1, Phase 2 | Status: COMPLETED